✦ LIBER ✦
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study
✍ Scribed by Shimon Slavin; Aliza Ackerstein; Reuven Or; Michael Y. Shapira; Benjamin Gesundheit; Nadir Askenasy; Shoshana Morecki
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 287 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.